Pharmaceuticals and the developing world

Journal of Economic Perspectives

Volumn 16, Issue 4, 2002, Pages 67-90

  Kremer, Michael ^a,b,c  

^a HARVARD UNIVERSITY   (United States)

^b BROOKINGS INSTITUTION   (United States)

^c NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

DEVELOPING COUNTRY; DRUG INDUSTRY; DRUG THERAPY; DRUG UTILIZATION; ECONOMICS; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; PHARMACOECONOMICS; REVIEW; UNITED STATES;

DEVELOPING COUNTRIES; DRUG INDUSTRY; DRUG THERAPY; DRUG UTILIZATION; ECONOMICS, PHARMACEUTICAL; HEALTH CARE SECTOR; HEALTH POLICY; HUMANS; PHARMACEUTICAL PREPARATIONS; UNITED STATES;

EID: 0040671438     PISSN: 08953309     EISSN: None     Source Type: Journal    
DOI: 10.1257/089533002320950984     Document Type: Review

References (61)

1. Adams, Gregor et al. 2001. "Consensus Statement on Antiretroviral Treatment for AIDS in Poor Countries." Available at 〈http://www. hsph.harvard.edu/organizations/hai/overview/ news_events/events/consensus.html〉.
2. Ammassari, Adriana et al. 2001. "Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons with HIV Infection." Journal of Acquired Immune Deficiency Syndromes. December 15, 28:5, pp. 445-49.
3. Attaran, Amir and Lee Gillespie-White. 2001. "Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment in Africa?" Journal of the American Medical Association. October 17, 286: 15, pp. 1886-892.
4. Balke, Nathan S. and Robert J. Gordon. 1989. "The Estimation of Prewar Gross National Product: Methodology and New Evidence." Journal of Political Economy. February, 97, pp. 38-92.
5. Batson, Amie and Martha Ainsworth. 2001. "Private Investment in AIDS Vaccine Development: Obstacles and Solutions." Bulletin of the World Health Organization. 79:8, pp. 721-27.
6. Brook, M.G. et al. 2001. "Adherence to Highly Active Antiretroviral Therapy in the Real World: Experience of Twelve English HIV Units." AIDS Patient Care STDS. September, 15:9, pp. 491-94.
7. Brown, Gordon. 2001. Speech given by Gordon Brown, Chancellor of the Exchequer, at the International Conference Against Child Poverty, London, February 26. Available at 〈http://www. hm-treasury.gov.uk/docs/2001/child_povesrty/ chxspeech.htm〉.
8. CMH (Commission on Macroeconomics and Health). 2001. "Macroeconomics and Health: Investing for Health." Available at 〈http://www. cid.harvard.edu/cidcmh/CMHReport.pdf〉.
9. Costa, Dora. 2001. "Estimating Real Income in the United States from 1988 to 1994: Correcting CPI Bias Using Engel Curves." Journal of Political Economy. December, 109:6, pp. 1288-310.
10. Crossette, Barbara. 1998. "At W.H.O., 2 Physicians Lead the Race for Top Job." New York Times. January 11, Section 1, p. 4.
11. (Children's Vaccine Initiative). 1999. CVI Forum No. 16. Geneva.
12. Das, Jishnu. 2000. "Do Patients Learn About Doctor Quality?: Theory and an Application to India." Manuscript, Harvard.
13. Desowitz, Robert S. 1991. The Malaria Capers: Tales of Parasites and People. New York: W. W. Norton.
14. Di Tella, Rafael and Ernesto Schargrodsky. 2001. "The Role of Wages and Auditing during a Crackdown on Corruption in the City of Buenos Aires." Manuscript, Harvard.
15. Elliott, Larry and Mark Atkinson. 2001. "Fund to Beat Third World Disease." Guardian. February 23. Available at 〈http://wxvw.guardian.co.uk/ international/story/0,3604,441835,00.html〉.
16. "Discovering Medicines for the Poor." 2000. Financial Times. February 2, p. 7.
17. Fogel, Robert W. 1986. "Nutrition and the Decline in Mortality Since 1700: Some Preliminary Findings," in Long-Term Factors in American Economic Growth. Stanley L. Engerman and Robert E. Gallman, eds. Chicago: University of Chicago Press, pp. 439-527.
18. Friedman, Milton and Rose Friedman. 1980. Free to Choose. New York: Harcourt Brace Jovanovich.
19. Glennerster, Rachel and Michael Kremer. 2001. "A Vaccine Purchase Commitment: Cost-Effectiveness Estimates and Pricing Guidelines." Unpublished Manuscript.
20. Jamison, Dean T. et al. 2001. "Cross-Country Variation in Mortality Decline, 1962-87: The Role of Country-Specific Technical Progress." CMH Working Paper No. WG1 :4, April.
21. Johnston, Louis and Samuel H. Williamson. 2002. "The Annual Real and Nominal GDP for the United States, 1789-Present." Economic History Services, April, available at 〈http:// www.eh.net/hmit/gdp/〉.
22. Kamat, Vinay R. and Mark Nichter. 1998. "Pharmacies, Self-Medication and Pharmaceutical Marketing in Bombay, India." Social Science and Medicine. 47:6, pp. 779-94.
23. Kettler, Hannah E. 1999. "Updating the Cost of a New Chemical Entity." London, Office of Health Economics.
24. Kim-Farley, R. and the Expanded Programme on Immunization Team. 1992. "Global Immunization." Annual Review of Public Health. 13, pp. 223-37.
25. Kremer, Michael. 2001a. "Creating Markets for New Vaccines: Part I: Rationale," in Innovation Policy and the Economy. Adam B. Jaffe, Josh Lerner, and Scott Stern, eds. Cambride: MIT Press, pp. 35-72.
26. Kremer, Michael. 2001b. "Creating Markets for New Vaccines: Part II: Design Issues," in Innovation Policy and the Economy. Adam B. Jaffe, Josh Lerner, and Scott Stern, eds. Cambride: MIT Press, pp. 73-118.
27. Kremer, Michael and Jeffrey Sachs. 1999. "A Cure for Indifference." Financial Times. May 5, available at 〈http://www.brook.edu/views/oped/ kremer/19990505.htm〉.
28. Kurian, George Thomas. 1994. Datapedia of the United States 1790-2000. Lanham, Md.: Bernan Press.
29. Lanjouw, Jean O. 2001. "A Patent Policy Proposal for Global Diseases." Brookings Policy Brief, June.
30. Lanjouw, Jean O. and Iain M. Cockburn. 2001. "New Pills for Poor People? Empirical Evidence after GATT." World Development. 29:2, pp. 265-89.
31. Lehman, Stan et al. 2000. "Are At-Risk Populations Less Concerned about HIV Infection in the HAART Era?" San Francisco, CDC Seventh Conference on Retroviruses and Opportunistic Infections, January 30-February 2.
32. Leonard, Kenneth L. 2002. "When Both States and Markets Fail: Asymmetric Information and the Role of NGOs in African Health Care." International Review of Law and Economics. July, 22:1, pp. 61-81.
33. Marseille, E. et al. 1999. "Cost-Effectiveness of Single-Dose Nevirapine Regimen for Mothers and Babies to Decrease Vertical HIV-1 Transmission in Sub-Saharan Africa.-Lancet. September 4, 354:9181, pp. 803-09.
34. McGreal, Chris. 1996. "Horror Greets AIDS 'Miracle Cure.'" Guardian. May 25, p. 11.
35. Mercer Management Consulting. 1998. "HIV Vaccine Industry Study October-December 1998." World Bank Task Force on Accelerating the Development of an HIV/AIDS Vaccine for Developing Countries.
36. Miguel, Edward and Michael Kremer. 2002. "Worms: Education and Health Externalities in Kenya." Manuscript, Harvard.
37. Mitchell, Violaine S. et al. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, D.C.: National Academy Press.
38. Morantz, Alison and Robert Sloane. 2001. "Vaccine Purchase Commitment Contract: Legal Strategies for Ensuring Enforceability." Mimeo, Harvard University.
39. Murphy, Trudy V. et al. 2001a. "Intussusception Among Infants Given an Oral Rotavirus Vaccine." New England Journal of Medicine. February 22, 344:8, pp. 564-72.
40. Murphy, Trudy V. et al. 2001b. "Intussusception and an Oral Rotavirus Vaccine." New England Journal of Medicine. June 14, 344:24, pp. 1866-867.
41. Murray, Christopher J. L. and Alan D. Lopez. 1996. The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Global Burden of Disease and Injury Series, Volume 1. Cambridge, Mass.: Published by the Harvard School of Public Health on behalf of the World Health Organization and the World Bank, Distributed by Harvard University Press.
42. Neumann, Peter J. et al. 2000. "Are Pharmaceuticals Cost-Effective? A Review of the Evidence." Health Affairs. March/April. 19:2, pp. 92-109.
43. Nichter, Mark and Mimi Nichter. 1996. Anthropology and International Health: Asian Case Studies. Amsterdam: Gordon and Breach.
44. Nieuwkerk, P.T. et al. 2001. "Limited Patient Adherence to Highly Active Antiretroviral Therapy for HIV-1 Infection in an Observational Cohort Study." Archives of Internal Medicine. September 10, 161:16, pp. 1962-968.
45. NBH (National Institutes of Health). 2000. "Fact Sheet: Antimicrobial Resistance." Available at 〈http://www.niaid.nih.gov/ factsheets/antimicro. htm/〉, June.
46. Pecoul, Bernard et al. 1999. "Access to Essential Drugs in Poor Countries: A Lost Battle?" Journal of the American Medical Association. January 27, 281:4, pp. 361-67.
47. Phadke, Anant. 1998. Drug Supply and Use: Towards a Rational Policy in India. New Delhi: Sage Publications.
48. PhRMA. 2000. PhRMA Industry Profile 2000. Available at 〈http://www.phrma.org/publications/publications/profile00/〉.
49. PIU (Performance and Innovation Unit, Cabinet Office). 2001. "Tackling the Diseases of Poverty: Meeting the Okinawa/Millenium Targets for HIV/AIDS, Tuberculosis, and Malaria." London, May 8. Available at 〈http://www. cabinet-office.gov.uk/innovation/healthreport/ default.htm〉.
50. Preston, Samuel H. 1975. "The Changing Relation between Mortality and Level of Economic Development." Population Studies. July, 29:2, pp. 231-48.
51. Sachs, Jeffrey. 1999. "Helping the World's Poorest." Economist. August 14, 352:8132, pp. 17-20.
52. United States Census. 2000. Available at 〈http:// www.census.gov/dmd/www/2khome.htm〉.
53. Walley, John D. et al. 2001. "Effectiveness of the Direct Observation Component of DOTS for Tuberculosis: A Randomised Controlled Trial in Pakistan." Lancet. March 3, 357, pp. 664-69.
54. WHO (World Health Organization). 1996. Investing in Health Research and Development: Report of the Ad Hoc Committee on Health Research Relating to Future Intervention Options. Geneva: WHO.
55. WHO (World Health Organization). 2000. World Heath Report 2000. Geneva: WHO.
56. WHO (World Health Organization). 2001. World Heath Report. 2001. Geneva: WHO.
57. World Bank. 1999. Confronting AIDS: Public Priorities in a Global Epidemic. Washington, D.C.: Oxford University Press.
58. World Bank. 2001a. Immunization at a Glance. Washington, D.C.: World Bank, November.
59. World Bank. 2001b. World Development Indicators. Washington, D.C.: Oxford University Press.
60. WTO. 2001a. "Fact Sheet: TRIPS and Pharmaceutical Patents." April.
61. WTO. 2001b. "Declaration on the TRIPS Agreement and Public Health." Available at 〈http:// www-chil.wto-ministerial.org/english/thewto_e/ minist_e/min01_e/min01_14nov_e.htm〉.